Literature DB >> 10651860

Impaired cerebral autoregulation 24 h after induction of transient unilateral focal ischaemia in the rat.

D G MacGregor1, H V Carswell, D I Graham, J McCulloch, I M Macrae.   

Abstract

Cerebral blood flow (CBF) and cerebral autoregulation have been investigated 24 h after transient focal ischaemia in the rat. Cerebral blood flow was measured autoradiographically before and during a moderate hypotensive challenge, to test autoregulatory responses, using two CBF tracers, (99m)Tc-d,l-hexamethylproyleneamine oxide and 14C-iodoantipyrine. Prior to induced hypotension, CBF was significantly reduced within areas of infarction; cortex (28 +/- 20 compared with 109 +/- 23 mL/100 g/min contralateral to ischaemic focus, P = 0.001) and caudate (57 +/- 31 compared with 141 +/- 32 mL/100 g/min contralaterally, P = 0.005). The hypotensive challenge (mean arterial pressure reduced to 60 mmHg by increasing halothane concentration) did not compromise grey matter autoregulation in the contralateral hemisphere; CBF data were not significantly different at normotension and during hypotension. However, in the ipsilateral hemisphere, a significant volume of cortex adjacent to the infarct, which exhibited normal flow at normotension, became oligaemic during the hypotensive challenge (e.g. frontal parietal cortex 109 +/- 15% to 65 +/- 15% of cerebellar flow, P < 0.01). This resulted in a 2.5-fold increase in the volume of cortex which fell below 50% cerebellar flow (39 +/- 34 to 97 +/- 46 mm3, P = 0.003). Moderate hypotension induced a significant reduction in CBF in both ipsilateral and contralateral subcortical white matter (P < 0.01). In peri-infarct caudate tissue, CBF was not significantly affected by hypotension. In conclusion, a significant volume of histologically normal cortex within the middle cerebral artery territory was found to have essentially normal levels of CBF but impaired autoregulatory function at 24 h post-ischaemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10651860     DOI: 10.1046/j.1460-9568.2000.00880.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

Review 1.  Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.

Authors:  Xiaoming Hu; T Michael De Silva; Jun Chen; Frank M Faraci
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 2.  Cerebral vascular dysregulation in the ischemic brain.

Authors:  Alexander Kunz; Costantino Iadecola
Journal:  Handb Clin Neurol       Date:  2009

3.  Reduced microvascular volume and hemispherically deficient vasoreactivity to hypercapnia in acute ischemia: MRI study using permanent middle cerebral artery occlusion rat model.

Authors:  J Y Suh; Woo H Shim; Gyunggoo Cho; Xiang Fan; Seon J Kwon; Jeong K Kim; George Dai; Xiaoying Wang; Young R Kim
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-18       Impact factor: 6.200

4.  Neurovascular regulation in the ischemic brain.

Authors:  Katherine Jackman; Costantino Iadecola
Journal:  Antioxid Redox Signal       Date:  2015-01-10       Impact factor: 8.401

Review 5.  Role of cannabinoids and endocannabinoids in cerebral ischemia.

Authors:  Cecilia J Hillard
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

6.  Dynamic cerebral autoregulation is transiently impaired for one week after large-vessel acute ischemic stroke.

Authors:  Nils H Petersen; Santiago Ortega-Gutierrez; Andrés Reccius; Arjun Masurkar; Amy Huang; Randolph S Marshall
Journal:  Cerebrovasc Dis       Date:  2015-02-03       Impact factor: 2.762

Review 7.  Cerebral Autoregulation in Stroke.

Authors:  Pedro Castro; Elsa Azevedo; Farzaneh Sorond
Journal:  Curr Atheroscler Rep       Date:  2018-05-21       Impact factor: 5.967

8.  Blood Pressure Variability Indices for Outcome Prediction After Thrombectomy in Stroke by Using High-Resolution Data.

Authors:  Corinne Inauen; Jens M Boss; Mira Katan; Andreas R Luft; Zsolt Kulcsar; Jan F Willms; Stefan Y Bögli; Emanuela Keller
Journal:  Neurocrit Care       Date:  2022-05-23       Impact factor: 3.532

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.